
EVANSTON, Ill. -- Targeted drug-delivery systems hold significant promise for treating cancer effectively by sparing healthy surrounding tissues.
A Northwestern University research team has developed a new way to determine whether or not single drug-delivery nanoparticles will successfully hit their intended targets -- by simply analyzing each nanoparticle's distinct movements in real time.
By studying drug-loaded gold nanostars on cancer cell membranes, the researchers found that nanostars designed to target cancer biomarkers transited over larger areas and rotated much faster than their non-targeting counterparts.
"Moving forward, this information can be used to compare how different nanoparticle characteristics -- such as particle size, shape and surface chemistry -- can improve the design of nanoparticles as targeting, drug-delivery agents," said Northwestern's Teri Odom, who led the study.
The study published today (Aug. 9) in the journal ACS Nano.
Odom is the Charles E. and Emma H. Morrison Professor of Chemistry in Northwestern's Weinberg College of Arts and Sciences.